A detailed history of Adar1 Capital Management, LLC transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 403,716 shares of SPRB stock, worth $157,449. This represents 0.03% of its overall portfolio holdings.

Number of Shares
403,716
Previous 355,216 13.65%
Holding current value
$157,449
Previous $184 Million 4.26%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.42 - $0.59 $20,370 - $28,615
48,500 Added 13.65%
403,716 $192 Million
Q2 2024

Aug 13, 2024

SELL
$0.51 - $0.85 $5,100 - $8,500
-10,000 Reduced 2.74%
355,216 $184 Million
Q1 2024

May 15, 2024

BUY
$0.7 - $5.49 $255,651 - $2.01 Million
365,216 New
365,216 $287 Million

Others Institutions Holding SPRB

About SPRUCE BIOSCIENCES, INC.


  • Ticker SPRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,560,200
  • Market Cap $9.19M
  • Description
  • Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...
More about SPRB
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.